Yvette C. Terrie, RPh, shares insights into addressing non-adherence and motivating patients to adhere to medication recommendations and health practices.
Living donor liver transplants (LDLT) from directed and non-directed living donors continue to expand the organ donor pool in the United States, shortening wait times for surgery, lowering Model for End-Stage Liver Disease...
Compared with caval sparing, total caval replacement for recipient hepatectomy in liver transplant may protect against post-transplant tumor recurrence.
Refinement in microsurgical biliary reconstruction techniques has led to a decrease in early biliary complications after living donor liver transplant.
Diagnosing antibody-mediated rejection in liver transplant recipients is hindered by a lack of biomarkers and co-occurrence of rejection and allograft damage.